We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 7,331 results
  1. Immunotherapy with subcutaneous immunoglobulin or plasmapheresis in patients with postural orthostatic tachycardia syndrome (POTS)

    Background

    Postural orthostatic tachycardia syndrome (POTS), one of the most common autonomic disorders, is associated with significant morbidity and...

    Katrina Kesterson, Jill Schofield, Svetlana Blitshteyn in Journal of Neurology
    Article 26 August 2022
  2. Does skin prick test response intensity predict symptom severity and efficacy of subcutaneous immunotherapy in allergic rhinitis?

    Objectives

    To investigate the effect of response intensity of allergen skin prick test (SPT) on symptom severity and long-term efficacy of dust mite...

    Xuan Yuan, Shaobing **e, ... Zhihai **e in European Archives of Oto-Rhino-Laryngology
    Article 16 September 2023
  3. Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization

    Background

    The efficacy of immune checkpoint inhibitors (ICIs) in hepatocellular carcinoma (HCC) is poor and great heterogeneity among individuals....

    Wenxin Xu, Jialei Weng, ... Yinghao Shen in Cancer Immunology, Immunotherapy
    Article Open access 17 February 2024
  4. Systemic reactions to subcutaneous allergen immunotherapy: real-world cause and effect modelling

    Background

    Subcutaneous immunotherapy (SCIT) is an effective treatment for allergic rhinoconjunctivitis. However, adverse events, including...

    Adam Aue, Joella Ho, ... Samira Jeimy in Allergy, Asthma & Clinical Immunology
    Article Open access 06 July 2021
  5. Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer

    Background

    Neoadjuvant immunotherapy with programmed death-ligand 1 blockade for colon cancer, especially for mismatch repair-deficient (dMMR)/high...

    Yuan Li, Weili Zhang, ... Zhenhai Lu in Targeted Oncology
    Article 30 April 2024
  6. Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis

    Background

    Allergy immunotherapy (AIT), in the form of subcutaneous immunotherapy (SCIT) with alum-precipitated aqueous extracts, SCIT with a modified...

    Anne K. Ellis, Douglas P. Mack, ... Sheena Gosain in Allergy, Asthma & Clinical Immunology
    Article Open access 18 January 2023
  7. Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma

    Immunotherapy, particularly immune checkpoint inhibitors (ICIs), such as anti-programmed death 1/programmed death-ligand 1 (PD-1/PD-L1) therapy, has...

    **n Liu, Hui Shen, ... Bin Zhang in npj Precision Oncology
    Article Open access 16 May 2024
  8. Clinical and Laboratory Profile of Patients with Anaphylaxis To Fire Ant Venom (Solenopsis sp.) Under Subcutaneous Immunotherapy

    Anaphylaxis to fire ant venom ( Solenopsis sp.) is a significant cause of systemic allergic reactions caused by Hymenoptera stings in children. There...

    Alexandra Sayuri Watanabe, Marcelo Alves Ferreira, ... Fabio Fernandes Morato Castro in SN Comprehensive Clinical Medicine
    Article 05 March 2022
  9. The Roots and Growth of Allergen Immunotherapy

    Purpose of Review

    The purpose of this review is to present the history of allergen immunotherapy.

    Recent Findings

    An overview of allergen...

    Article 28 September 2023
  10. Immunotherapy Update: What Delivery Techniques Are Available?

    Purpose of the Review

    To summarize the different delivery techniques studied for the administration of allergen immunotherapy.

    Recent Findings ...
    Article 03 March 2022
  11. Intratumoural immunotherapy plus focal thermal ablation for localized prostate cancer

    Major advances have been made in the use of immunotherapy for the treatment of solid tumours, including the use of intratumourally injected...

    Denis Séguier, Eric S. Adams, ... Thomas J. Polascik in Nature Reviews Urology
    Article 19 December 2023
  12. Topical cyclosporine versus allergen specific immunotherapy in perennial allergic conjunctivitis

    Purpose

    Symptom control in the long-term with less side effects is important in perennial allergic conjunctivitis, since would improve quality of...

    Ceylan Uslu Dogan, Can Tuzer, ... Semra Demir in International Ophthalmology
    Article 14 December 2022
  13. Emerging evidence for adapting radiotherapy to immunotherapy

    Immunotherapy has revolutionized the clinical management of many malignancies but is infrequently associated with durable objective responses when...

    Lorenzo Galluzzi, Molykutty J. Aryankalayil, ... Silvia C. Formenti in Nature Reviews Clinical Oncology
    Article 06 June 2023
  14. Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases

    Background

    Allergen immunotherapy (AIT) is the only causal therapy for IgE-mediated allergy. There is less evidence about the safety and efficacy of...

    Yaqi Yang, Dongxia Ma, ... Rongfei Zhu in Italian Journal of Pediatrics
    Article Open access 23 April 2021
  15. A single centre retrospective study of systemic reactions to subcutaneous immunotherapy

    Background

    Subcutaneous immunotherapy (SCIT) is the standard approach for treating patients with sensitizations to aeroallergens. However,...

    Kara Robertson, Nazanin Montazeri, ... Harold Kim in Allergy, Asthma & Clinical Immunology
    Article Open access 02 November 2020
  16. Ultrasound and CT findings of subcutaneous metastases in trunk and pelvis: a comprehensive analysis

    Objective

    This study aimed to describe the ultrasound, CT findings, and clinical manifestations of pathologically confirmed metastases involving the...

    Yeo ** Kim, Hyun Su Kim, ... Young Cheol Yoon in Skeletal Radiology
    Article 10 May 2024
  17. Advances in nano-immunotherapy for hematological malignancies

    Hematological malignancies (HMs) encompass a diverse group of blood neoplasms with significant morbidity and mortality. Immunotherapy has emerged as...

    Jian Xu, Wenqi Liu, ... Yu Hu in Experimental Hematology & Oncology
    Article Open access 25 May 2024
  18. Potential roles of sex-linked differences in obesity and cancer immunotherapy: revisiting the obesity paradox

    Obesity, a condition of excess adiposity usually defined by a BMI > 30, can have profound effects on both metabolism and immunity, connecting the...

    Logan V. Vick, Spencer Rosario, ... William J. Murphy in npj Metabolic Health and Disease
    Article Open access 23 May 2024
  19. Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

    Cancer immunotherapy and vaccine development have significantly improved the fight against cancers. Despite these advancements, challenges remain,...

    Qiang Lu, Dongquan Kou, ... Peng Han in Journal of Hematology & Oncology
    Article Open access 02 April 2024
  20. Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia

    Allogeneic natural killer (NK) cell-based immunotherapy is a promising, well-tolerated adjuvant therapeutic approach for acute myeloid leukemia...

    P. K. J. D. de Jonge, P. M. M. van Hauten, ... H. Dolstra in Cancer Immunology, Immunotherapy
    Article Open access 21 July 2023
Did you find what you were looking for? Share feedback.